|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alzheimer Disease | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Tauopathies | |||||
| 3 | Interventions listed in this trial | ||||
| Donepezil | |||||
| Estrogen | |||||
| Progesterone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Progestins | |||||
| 5 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| Alzheimer's Association | |||||
| Pfizer | |||||
| Eisai Inc. | |||||